Regencell Bioscience Holdings Ltd
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q3 25 | Q4 25 | Q1 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -99.9% | +99,906.0% | -17.0% | +0.0% | -19.4% | +0.0% | -11.4% | +0.0% | -23.0% | -47.6% | +0.0% | |
| – | -99.9% | +99,903.0% | -15.4% | +0.0% | -17.5% | +0.0% | -18.8% | +0.0% | -25.6% | -51.9% | +0.0% | |
| – | – | +99,899.7% | +206.7% | +0.0% | -38.3% | +0.0% | +0.0% | – | – | – | – | |
| – | – | +99,906.9% | -58.5% | +0.0% | +65.9% | +0.0% | +0.0% | – | – | – | – | |
| – | – | – | +0.0% | – | – | – | +0.0% | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -99.9% | +99,900.0% | -50.6% | +0.0% | -29.8% | +0.0% | +248.0% | +0.0% | +17.2% | +100.4% | +0.0% | |
| – | – | +99,900.7% | +0.0% | – | – | +0.0% | +0.0% | – | – | – | – | |
| – | – | +0.0% | +0.0% | – | – | +0.0% | +100.0% | – | – | – | – | |
| – | -99.9% | +99,902.8% | -15.5% | +0.0% | -19.1% | +0.0% | -18.3% | +0.0% | -27.6% | -74.9% | +0.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -97.4% | +3,700.3% | 0.0% | +0.0% | +0.0% | +0.0% | +0.0% | 0.0% | +0.0% | +0.0% | +0.0% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.